The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of camrelizumab combined with FOLFOX as neoadjuvant therapy for patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy.
 
Yuzhou Zhao
No Relationships to Disclose
 
Guangsen Han
No Relationships to Disclose
 
Jing Zhuang
No Relationships to Disclose
 
Zhimeng Li
No Relationships to Disclose
 
Gangcheng Wang
No Relationships to Disclose
 
Baodong Li
No Relationships to Disclose
 
Jinbang Wang
No Relationships to Disclose
 
Yanhui Gu
No Relationships to Disclose
 
Pengfei Ma
No Relationships to Disclose
 
Junli Zhang
No Relationships to Disclose
 
Yanghui Cao
No Relationships to Disclose
 
Chenyu Liu
No Relationships to Disclose
 
Sen Li
No Relationships to Disclose
 
Xijie Zhang
No Relationships to Disclose